)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Pharmicell
Pharmicell (005690) investor relations material
Pharmicell Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary12 Aug, 2026
Executive summary
Operates two main divisions: Bio-Medical (stem cell therapies, storage, cosmetics) and Bio-Chemical (pharmaceutical intermediates, specialty chemicals).
Listed on KOSPI since 1988, with no subsidiaries or affiliates as of the reporting date.
Significant R&D focus, with multiple clinical trials and government-supported projects in progress.
Financial highlights
Revenue for H1 2026: KRW 75.7 billion, down from KRW 114.1 billion in H1 2025.
Operating income: KRW 26.3 billion (H1 2026), down from KRW 34.3 billion (H1 2025).
Net income: KRW 22.1 billion (H1 2026), down from KRW 40.3 billion (H1 2025).
Basic EPS: KRW 368 (H1 2026) vs. KRW 671 (H1 2025).
Cash and equivalents at period end: KRW 15.0 billion, down from KRW 28.9 billion at prior year-end.
Outlook and guidance
Continued investment in R&D, especially for stem cell therapies and pharmaceutical intermediates.
Ongoing construction of Ulsan Plant 3 to expand production capacity for AI materials and pharmaceutical ingredients.
Plans to balance shareholder returns with growth investments; no changes to dividend policy.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmicell
- H1 2024 saw lower sales and profit, but Bio-Chemical remains the main growth engine.005690
Q2 2024 - Q3 2024 revenue dropped 22.8% YoY to ₩43.4B, with net income at ₩2.18B.005690Q3 2024
- 2024 revenue up 15% and net income up 77%, led by Bio-Chemical growth and margin gains.005690Q4 2024
- Q1 2025 revenue and profit soared on Bio-Chemical strength and robust R&D pipeline.005690Q1 2025
- Revenue and profit surged on Bio-Chemical growth, with robust cash flow and new plant investment.005690Q3 2025
- Revenue and profit surged on Bio Chemical growth and AI material demand, with strong margins.005690Q4 2025
- Operating and net income surged in H1 2025 despite lower revenue, led by Bio-Chemical sales.005690Q2 2025
- Q1 FY2026 revenue and net income surged, driven by Bio-Chemical sales and robust margins.005690Q1 2026
Next Pharmicell earnings date
Q3 202612 Nov, 2026
Pharmicell
Next Pharmicell earnings date
Q3 202612 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage